Evaluation of the Correlation Between Coronary Microvascular Resistance Based on Quantitative Flow Ratio and Major Adverse Cardiovascular Events in Patients With Obstructive Hypertrophic Cardiomyopathy: A Retrospective Cohort Study
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- China National Center for Cardiovascular Diseases
- Enrollment
- 340
- Locations
- 1
- Primary Endpoint
- The Major Adverse Cardiovascular Events related to HoCM
Overview
Brief Summary
About 60% of patients with hypertrophic cardiomyopathy have microvascular dysfunction. Microvascular dysfunction is directly related to prognosis in hypertrophic cardiomyopathy. This new measurement method is microcirculation resistance (MR) based on quantitative flow ratio (QFR), which does not need a pressure guide wire on the basis of angiography. The QFR system is used to evaluate the blood vessels distal pressure and blood flow, and their ratio is microcirculation resistance (MR). The quantitative blood flow fraction measurement system was analyzed by interventional laboratory platform image analysis software (AngioPlus 2.0). This study is a single-center retrospective cohort study. Participants were selected from patients who were diagnosed with hypertrophic obstructive cardiomyopathy in Fuwai Hospital from January 2020 to November 2021. The risk factor is whether there is microcirculation resistance disorder. The outcome was the major adverse cardiovascular events related to HCM (including all-cause death, heart transplantation, left ventricular pacemaker, and heart failure readmission) that were followed up one year after angiography. Aim To further clarify whether there is a certain correlation between microvascular resistance and adverse cardiovascular prognosis.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
The Major Adverse Cardiovascular Events related to HoCM
Time Frame: One-year followed up after angiography
including all-cause death, heart transplantation, left ventricular pacemaker, heart failure readmission
Secondary Outcomes
- Borg Index after 6MWT(One-year followed up after angiography)
- Scale of KCCQ-12(One-year followed up after angiography)
Investigators
Lihong Ma
Director of Department of Traditional Chinese Medicine, Principal Investigator, Clinical Professor
China National Center for Cardiovascular Diseases